Duchemann B, Remon J, Naigeon M, Mezquita L, Ferrara R, Cassard L, Jouniaux JM, Boselli L, Grivel J, Auclin E, Desnoyer A, Besse B, Chaput N. Integrating Circulating Biomarkers in the Immune Checkpoint Inhibitor Treatment in Lung Cancer. Cancers (Basel). 2020 Dec 3;12(12):3625. doi: 10.3390/cancers12123625.PMID: 33287347; PMCID: PMC7761725.

Blanc D, Racine V, Khalil A, Deloche M, Broyelle JA, Hammouamri I, Sinitambirivoutin E, Fiammante M, Verdier E, Besson T, Sadate A, Lederlin M, Laurent F, Chassagnon G, Ferretti G, Diascorn Y, Brillet PY, Cassagnes L, Caramella C, Loubet A, Abassebay N, Cuingnet P, Ohana M, Behr J, Ginzac A, Veyssiere H, Durando X, Bousaïd I, Lassau N, Brehant J. Artificial intelligence solution to classify pulmonary nodules on CT. Diagn Interv Imaging. 2020 Dec;101(12):803-810. doi: 10.1016/j.diii.2020.10.004. Epub 2020 Nov 7. PMID: 33168496.

Besnard V, Jeny F. Models Contribution to the Understanding of Sarcoidosis Pathogenesis: "Are There Good Models of Sarcoidosis?". J Clin Med. 2020 Jul 31;9(8):2445. doi: 10.3390/jcm9082445. PMID: 32751786; PMCID: PMC7464295.

Jeny F, Grutters JC. Experimental models of sarcoidosis: where are we now? Curr Opin Pulm Med. 2020 Sep;26(5):554-561. doi: 10.1097/MCP.0000000000000708. PMID: 32701674.

Sesé L, Khamis W, Jeny F, Uzunhan Y, Duchemann B, Valeyre D, Annesi-Maesano I, Nunes H. Adult interstitial lung diseases and their epidemiology. Presse Med. 2020 Jun;49(2):104023. doi: 10.1016/j.lpm.2020.104023. Epub 2020 May 11. PMID:32437842.

Sesé L, Jeny F, Uzunhan Y, Khamis W, Freynet O, Valeyre D, Bernaudin JF, Annesi-Maesano I, Nunes H. Rôle de la pollution au cours des pneumopathies interstitielles diffuses [The effect of air pollution in diffuse interstitial lung disease]. Rev Mal Respir. 2020 May;37(5):389-398. French. doi:10.1016/j.rmr.2020.02.015. Epub 2020 Apr 8. PMID: 32278507.

Jeny F, Bernaudin JF, Valeyre D, Nunes H, Planès C, Besnard V. L’hypoxie est-elle un facteur impactant l’évolution de la sarcoïdose pulmonaire ? [Is hypoxia a factor in the progression of pulmonary sarcoidosis?]. Rev Mal Respir. 2020 Mar;37(3):214-217. French. doi: 10.1016/j.rmr.2020.02.006. Epub 2020 Mar 4. PMID: 32146058.

Yegen CH, Haine L, Marchant D, Boncoeur E, Voituron N. Caractérisation du rôle protecteur de l’érythropoïétine dans un modèle murin d’agression pulmonaire aiguë [Characterisation of the protective role of erythropoetin in a murine model of acute lung injury]. Rev Mal Respir. 2020 Mar;37(3):193-196. French. doi: 10.1016/j.rmr.2020.02.005. Epub 2020 Mar 4. PMID: 32146057.

Calender A, Weichhart T, Valeyre D, Pacheco Y. Current Insights in Genetics of Sarcoidosis: Functional and Clinical Impacts. J Clin Med. 2020 Aug 13;9(8):2633. doi: 10.3390/jcm9082633. PMID: 32823753; PMCID: PMC7465171.

Rossi G, Ziol M, Roulot D, Valeyre D, Mahévas M. Hepatic Sarcoidosis: Current Concepts and Treatments. Semin Respir Crit Care Med. 2020 Oct;41(5):652-658. doi: 10.1055/s-0040-1713799. Epub 2020 Aug 10. PMID:32777850.

Patel DC, Valeyre D. Advanced pulmonary sarcoidosis. Curr Opin Pulm Med. 2020 Sep;26(5):574-581. doi: 10.1097/MCP.0000000000000705. PMID: 32740378.

El Jammal T, Jamilloux Y, Gerfaud-Valentin M, Valeyre D, Sève P. Refractory Sarcoidosis: A Review. Ther Clin Risk Manag. 2020 Apr 17;16:323-345. doi: 10.2147/TCRM.S192922. PMID: 32368072; PMCID: PMC7173950.

Pacheco Y, Lim CX, Weichhart T, Valeyre D, Bentaher A, Calender A. Sarcoidosis and the mTOR, Rac1, and Autophagy Triad. Trends Immunol. 2020 Apr;41(4):286-299. doi: 10.1016/j.it.2020.01.007. Epub 2020 Feb 28. PMID:32122794.

CrossTalk opposing view: Barometric pressure, independent of PO2, is not the forgotten parameter in altitude physiology and mountain medicine. Richalet JP. J Physiol. 2020 Mar;598(5):897-899. doi: 10.1113/JP279160. Epub 2020 Feb 13. PMID: 32053235